Bajaj Healthcare to resume commercial production of Citicoline Sodium

11 May 2022 Evaluate

Bajaj Healthcare (BHL) is all set to start commercial production of Citicoline Sodium, at the plant located at Panoli, Gujarat. The plant was involved in a fire incident last year and is now ready to commence operations at upgraded capacities. Citicoline Sodium is used to help memory loss due to aging, improve vision in people with glaucoma, and also helps with recovery in stroke patients & is administered as an injection or taken orally.

The plant will commence operations with an upgraded capacity of almost 2X of its previous installed capacity, not only in terms of the API but also its required intermediate as well. Equipped with the latest technology & increased efficiencies, the company will now also produce the Intermediate required for the product at the Panoli plant itself, which was previously being sourced from a different facility under BHL’s management. BHL plans to cater to the expanding demand of the product with a positive impact on its margins owing to better realization margins on the product. The plant at Panoli has been upgraded as per the latest technology confirming to the Good Manufacturing Practices (GMP) standards issued by NSF International, which are at par to international standards for pharmaceutical manufacturing

Bajaj Healthcare mainly focuses on development, manufacturing and supply of Amino Acids, Nutritional Supplements and Active Pharmaceutical Ingredients (API) for Pharmaceutical, Nutraceuticals and Food industries.

Bajaj Healthcare Share Price

559.00 89.90 (19.16%)
18-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1800.30
Dr. Reddys Lab 1275.05
Cipla 1472.05
Lupin 2098.70
Zydus Lifesciences 979.10
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.